Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL15P1 (ribosomal protein L15 pseudogene 1) is a pseudogene—a non-functional segment of DNA—related to the functional ribosomal protein L15 gene (*RPL15*). Pseudogenes such as RPL15P1 do not encode functional proteins, nor do they possess enzymatic or receptor activity. They are distinct from protein-coding genes and are not considered therapeutic targets. RPL15P1 has been indexed with alternative names like dJ726N1.3 and RPL15_9_1687, but there is no evidence suggesting biological function, disease association, or clinical relevance as seen with its parent gene, RPL15[1][8]. No drugs are known to interact with this pseudogene, and it is not used as a biomarker. \nIn summary, the designation "RPL15P1" refers to a **nonfunctional pseudogene** rather than a gene product with pharmacological or physiological relevance. Any references to disease or therapy are likely misattributed if attached to RPL15P1 itself, rather than the functional *RPL15* gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 1 (RPL15P1).